谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Exceptional Sustained Long-Term Complete Response to Tepotinib in a MET-amplified Advanced Intrahepatic Biliary Tract Cancer Failing Durvalumab Plus Cisplatin and Gemcitabine

Andreas Reichinger, Leo Essl, Paul Kerschner,Jonathan Burghofer,Gerald Webersinke,Holger Rumpold,Bernhard Doleschal

The oncologist（2024）

引用 0|浏览3
关键词
MET amplification,TP53 mutation,Tepotinib,biliary tract cancer,Durvalumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要